Materials for the 2023 Annual Shareholders Meeting.
Announcement regarding the release of pledge of shares by shareholders holding more than 5% of the shares.
Announcement Regarding Changes in Shareholder Rights with Over 5% of Shares
Simplified Equity Change Report
Notice on the convening of the 2023 annual shareholder meeting.
Announcement of Resolutions from the 20th Meeting of the Second Board of Directors.
Announcement of Resolutions of the 18th Meeting of the Second Board of Supervisors.
Announcement of Shanghai Cathay Biotech Inc. regarding the extension of the validity period of the resolution concerning the issuance of A shares of the company to specific objects in 2023 and the authorization period.
Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Announcement Regarding the Re-hiring of Accounting Firm.
Announcement of the shareholders' holdings reduction period halfway and the progress of the reduction
Shanghai Kaisai Biotechnology Co., Ltd. Non-recurring profit and loss certification report
Announcement of Resolutions of the 17th Meeting of the Second Board of Supervisors
Tianjian Certified Public Accountants (Special General Partnership) Audit Report on the Use of Funds Previously Raised by Shanghai Kaisai Biotechnology Co., Ltd.
CITIC Securities Co., Ltd. summary report on Shanghai Kaisai Biotechnology Co., Ltd.'s initial public offering of shares and continued supervision and sponsorship of its listing on the Science and Technology Innovation Board
China Merchants Securities Co., Ltd. summary report on Shanghai Kaisai Biotechnology Co., Ltd.'s initial public offering of shares and continued supervision and sponsorship of its listing on the Science and Technology Innovation Board
Report on the use of funds raised last time
Announcement on the cancellation of the pledge of some shares of shareholders holding 5% or more of the shares
Announcement on holding the 2023 Annual Results Briefing
CITIC Securities Co., Ltd.'s 2023 Continuous Supervision Work Site Inspection Report on Shanghai Kaisai Biotechnology Co., Ltd.
No Data